Report copyright - Les lymphomes cutanés en 2016...3 centres EU, 3 centres US • Dose-escalation Part: accelerated 3+3 design pts with KIR3DL2+ tumors all CTCL subtypes eligible Recommended Phase II
Please pass captcha verification before submit form